Long-acting HIV medicines have the potential to transform both treatment and prevention, reducing pill burden, improving adherence, and better reflecting what people living with or at risk of HIV consistently say they want. Yet despite their promise, access to these innovations remains limited, particularly in low- and middle-income countries (LMICs). A paper published in February […]
08 July 2026
Keyword